Jan. 31 at 3:00 AM
$AKBA Change is in the air
As jan 2026 ends and Feb 1st is upon us, all of USRC clinics are now at TIW Vafseo dosing. It is also nice to look back at the past (multipart thread) as some here are so interested in R/S and why it was so good to stop that and thankfully, and to fire the CFO who even proposed such a stupid notion.
On April 11, 2023 was the vote stopping the R/S and then 5.6 million shares short out of 185 mm shares or 3%. Shares around
$0.55. Shorts expected a reverse split vote to go through. It did not, so they were in a predicament which they never recovered from.
They desperately needed a R/S, for example a 10:1 would allow 18.5 mm shares at
$5.5 and the short interest would be at 560k. The moment that happens there will be enough longs to sell their shares giving the shorts enough leeway to cover their short. They needed longs to sell in droves to cover without share price rocketing up. Most longs would sell if the R/S went through, especially retail.